AI주식인사이트AI Stock Insight
C

우진비앤지

018620KOSDAQ의약품 제조업

51.8 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40
News Sentiment21.3 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Rose 8.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ujin B&G is a specialized company in animal pharmaceuticals, producing medications, vaccines, and supplements, with 35% of its sales coming from exports. Its subsidiaries, OSPI and Bawow Korea, manufacture pet food and treats, and the company aims to expand its market share through eco-friendly products and vaccine development.

Number of Employees

103people

Average Salary

54.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 14.804.0Point
PBR
0.33Industry Average 1.047.0Point

Half of industry avg (excellent)

ROE
-5.38Industry Average 4.420.0Point

Well below industry avg

Debt Ratio
24.70Industry Average 11.980.0Point

2.1x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼25.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 728Won52-week high 1,00452-week low 670
1-month return5.0Point

1m +8.33% (rising)

Volume trend3.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
  • Neutral정기주주총회결과2026-03-27
  • Neutral사업보고서 (2025.12)2026-03-19
  • Neutral감사보고서제출2026-03-19